Within the context of COVID-19, while cTnT levels have shown promise as a prognostic factor for severity of illness, cTnI has been the more commonly reported metric for virus-related cardiac injury in COVID-19 patients [58,59]. The gene discussed is TNNT2; the disease is COVID-19.